How Rivals Built an ACO
So far the collaboration has focused on these strategies: increase generic drug use, reduce elective induction of labor before 39 weeks, reduce ED use by expanding urgent care options, and improved support for chronic care management.
In its first year of the seven-year collaboration, Wheeler says medical costs for the at-risk population were reduced by about $6 million, including $1 million by studying prescribing practices and shifting from brand-name to generic drugs. The total medical cost trend dropped from a 2009 growth rate of 8%, which was well above the area's average increase, to 3%, which is comparable to the area's average.
She credits a key investment in the development of advanced care teams as contributing to cost and outcome improvements. The teams, which consist of care managers and care guides, as well as social workers and pharmacists, work out of the alliance's primary care clinics. So far, the Alliance has reduced costly hospital admissions by 6% and contributed to a 5% reduction in ED use over the past year.
This article appears in the May 2012 issue of HealthLeaders magazine.
Margaret Dick Tocknell is a reporter/editor with HealthLeaders Media.
- Providers' Push to Consolidate Roils Payers
- As Retail Clinics Surge, Quality Metrics MIA
- Former NQF Co-Chair Linked to Conflicts of Interest in Journal Probe
- Medicare Cost, Quality Data Tools Weak, Says GAO
- CMS Mulls Income-Adjusting MA Stars
- 6 Not-So-Good Reasons for Avoiding Population Health
- No Employee Satisfaction, No Patient-Centered Culture
- Population Health Pays Off for NY Collaborative
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- RN Named Chief Patient Experience Officer